| http://www.w3.org/ns/prov#value | - ???AHF has repeatedly criticized Gilead and its CEO John Martin ??? whose income last year was $54 million ??? for price gouging on its HIV/AIDS treatments, an action that places the drugs out of reach for many patients due to increases in healthcare costs trickling down to government programs and insurers such as Medicare and Medicaid as well as private insurers and programs like the AIDS Drug As
|
